180 related articles for article (PubMed ID: 24146184)
1. Oxidative stress in diabetes - circulating advanced glycation end products, lipid oxidation and vascular disease.
Dias IH; Griffiths HR
Ann Clin Biochem; 2014 Mar; 51(Pt 2):125-7. PubMed ID: 24146184
[No Abstract] [Full Text] [Related]
2. Advanced glycation and endothelial functions: a link towards vascular complications in diabetes.
Rojas A; Morales MA
Life Sci; 2004 Dec; 76(7):715-30. PubMed ID: 15581904
[TBL] [Abstract][Full Text] [Related]
3. Importance of Metabolic Memory in the Development of Vascular Complications in Diabetic Patients.
Luna P; Guarner V; Farías JM; Hernández-Pacheco G; Martínez M
J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1369-78. PubMed ID: 27256447
[No Abstract] [Full Text] [Related]
4. [Advanced oxidation protein products. Part II. The significance of oxidation protein products in the pathomechanism of diabetes and its complications].
Piwowar A
Pol Merkur Lekarski; 2010 Mar; 28(165):227-30. PubMed ID: 20815174
[TBL] [Abstract][Full Text] [Related]
5. Atherosclerosis in chronic kidney disease: lessons learned from glycation in diabetes.
Mohar DS; Barseghian A; Haider N; Domanski M; Narula J
Med Clin North Am; 2012 Jan; 96(1):57-65. PubMed ID: 22391251
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of AGEs formation by natural products.
Nagai R; Shirakawa J; Ohno R; Moroishi N; Nagai M
Amino Acids; 2014 Feb; 46(2):261-6. PubMed ID: 23504149
[TBL] [Abstract][Full Text] [Related]
7. The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond.
Ramasamy R; Yan SF; Schmidt AM
Trends Cardiovasc Med; 2005 Oct; 15(7):237-43. PubMed ID: 16226677
[TBL] [Abstract][Full Text] [Related]
8. Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes.
Yamagishi S; Maeda S; Matsui T; Ueda S; Fukami K; Okuda S
Biochim Biophys Acta; 2012 May; 1820(5):663-71. PubMed ID: 21440603
[TBL] [Abstract][Full Text] [Related]
9. [Role of advanced glycosylation end products in the pathogenesis of hypertension].
Zukowska-Szczechowska E; Tomaszewski M; Grzeszczak W
Przegl Lek; 2003; 60(9):585-7. PubMed ID: 15065338
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress: a key contributor to diabetic cardiomyopathy.
Khullar M; Al-Shudiefat AA; Ludke A; Binepal G; Singal PK
Can J Physiol Pharmacol; 2010 Mar; 88(3):233-40. PubMed ID: 20393588
[TBL] [Abstract][Full Text] [Related]
11. [Oxidative stress and protein glycation in diabetes mellitus].
Gillery P
Ann Biol Clin (Paris); 2006; 64(4):309-14. PubMed ID: 16829472
[TBL] [Abstract][Full Text] [Related]
12. [Diabetes mellitus and osteoporosis. Bone quality in diabetes].
Saito M
Clin Calcium; 2012 Sep; 22(9):1323-32. PubMed ID: 22932286
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background.
Kalousová M; Zima T; Tesar V; Dusilová-Sulková S; Skrha J
Mutat Res; 2005 Nov; 579(1-2):37-46. PubMed ID: 16084533
[TBL] [Abstract][Full Text] [Related]
14. Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.
Aldini G; Vistoli G; Stefek M; Chondrogianni N; Grune T; Sereikaite J; Sadowska-Bartosz I; Bartosz G
Free Radic Res; 2013 Aug; 47 Suppl 1():93-137. PubMed ID: 23560617
[TBL] [Abstract][Full Text] [Related]
15. The role of oxidative stress in diabetes vascular disorders.
Mukherjee S
Curr Opin Lipidol; 2007 Dec; 18(6):696-8. PubMed ID: 17993816
[No Abstract] [Full Text] [Related]
16. Advanced glycation endproducts: what is their relevance to diabetic complications?
Ahmed N; Thornalley PJ
Diabetes Obes Metab; 2007 May; 9(3):233-45. PubMed ID: 17391149
[TBL] [Abstract][Full Text] [Related]
17. Glycated proteins in diabetes.
Furth AJ
Br J Biomed Sci; 1997 Sep; 54(3):192-200. PubMed ID: 9499597
[TBL] [Abstract][Full Text] [Related]
18. [Protein glycosylation end products].
Kropiewnicka EH; Paczek L
Pol Arch Med Wewn; 1998 Oct; 100(4):350-8. PubMed ID: 10335045
[No Abstract] [Full Text] [Related]
19. Skin beautification with oral non-hydrolized versions of carnosine and carcinine: Effective therapeutic management and cosmetic skincare solutions against oxidative glycation and free-radical production as a causal mechanism of diabetic complications and skin aging.
Babizhayev MA; Deyev AI; Savel'yeva EL; Lankin VZ; Yegorov YE
J Dermatolog Treat; 2012 Oct; 23(5):345-84. PubMed ID: 21756141
[TBL] [Abstract][Full Text] [Related]
20. Metabolic memory: implications for diabetic vascular complications.
Cooper ME
Pediatr Diabetes; 2009 Aug; 10(5):343-6. PubMed ID: 19490497
[No Abstract] [Full Text] [Related]
[Next] [New Search]
